QIAGEN Launches CE-marked Version of QuantiFERON SARS-CoV-2 to Assess T-cell Response to COVID-19
The QuantiFERON® SARS-CoV-2 assay detects CD4+ and CD8+ T-cell responses, thereby enabling a much more comprehensive assessment of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Dec 21
The QuantiFERON® SARS-CoV-2 assay detects CD4+ and CD8+ T-cell responses, thereby enabling a much more comprehensive assessment of…
03 Dec 21
The assay helps users to detect SARS-CoV-2, viral load and an early indication of the Omicron variant
03 Dec 21
The ReadyCheckGo program offers a variety of options designed specifically for the needs of K-12 schools
02 Dec 21
These new CE-marked multiplex kits have been specifically designed to detect and differentiate three viral infections in the…
02 Dec 21
The collaboration will use imaging, diagnostic and multi-omic capabilities to identify new, significant biomarkers for the detection of…
02 Dec 21
TIB Molbiol excels in ultra-rapid assay development for emerging infectious disease, strongly demonstrated during the COVID-19 pandemic
01 Dec 21
The SeptiCyte RAPID will help differentiate infection-positive (sepsis) from infection-negative systemic inflammation in patients suspected of sepsis
30 Nov 21
The company’s analysis of genetic sequences from over 175 Omicron-infected samples have shown that none of the new…
30 Nov 21
Accuracy of TaqPath Covid-19 assays is not impacted by the Omicron variant, and the test could indicate a…
29 Nov 21
The additional approval enables QIAGEN and DiaSorin to provide a suite of automation platforms for TB testing options…